Predictors of persistent inflammation in familial Mediterranean fever and association with damage.


Journal

Rheumatology (Oxford, England)
ISSN: 1462-0332
Titre abrégé: Rheumatology (Oxford)
Pays: England
ID NLM: 100883501

Informations de publication

Date de publication:
05 01 2021
Historique:
received: 25 02 2020
revised: 01 06 2020
pubmed: 12 8 2020
medline: 21 4 2021
entrez: 12 8 2020
Statut: ppublish

Résumé

Persistent inflammation is an insidious and less studied feature of FMF. We investigated clinical determinants of persistent inflammation and its associations with individual damage items. This is a cross-sectional analysis of 917 FMF patients, who fulfilled the Tel Hashomer criteria and had at least 6 months' follow-up. Patients were stratified based on whether they had persistent inflammation. We used logistic regression analysis to investigate independent predictors of persistent inflammation and the associated individual damage items. One hundred and forty-two (15%) patients had persistent inflammation. Active FMF (54%) was the most prominent reason for the persistent inflammation. Spondylarthritis (16%), other inflammatory arthritis (8%) and IBD (2%) were other frequent reasons. Male gender, history of exertional leg pain, inflammatory comorbidities, M694V homozygosity, colchicine resistance, lower education levels and musculoskeletal attack dominance were found to be the independent predictors of persistent inflammation. Earlier disease onset led to a tendency towards persistent inflammation. Patients with persistent inflammation were more likely to suffer damage. There is an increased risk of developing proteinuria, amyloidosis and renal insufficiency. We identified, for the first time, the predictors of persistent inflammation in adult FMF patients and related individual damage items of the Autoinflammatory Disease Damage Index. Persistent inflammation is insidious and one of the chief causes of damage; therefore, especially patients with these predictors should be followed up more closely. If detected, underlying inflammatory comorbidities should be assessed meticulously as early detection and proper treatment strategies may favourably impact the natural history of the disease.

Identifiants

pubmed: 32778893
pii: 5890686
doi: 10.1093/rheumatology/keaa378
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

333-339

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

Hakan Babaoglu (H)

Department of Internal Medicine, Division of Rheumatology, Faculty of Medicine, Gazi University, Ankara.

Berkan Armagan (B)

Department of Internal Medicine, Division of Rheumatology, Faculty of Medicine, Hacettepe University, Ankara.

Erdal Bodakci (E)

Department of Internal Medicine, Division of Rheumatology, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey.

Hasan Satis (H)

Department of Internal Medicine, Division of Rheumatology, Faculty of Medicine, Gazi University, Ankara.

Nuh Atas (N)

Department of Internal Medicine, Division of Rheumatology, Faculty of Medicine, Gazi University, Ankara.

Alper Sari (A)

Department of Internal Medicine, Division of Rheumatology, Faculty of Medicine, Hacettepe University, Ankara.

Nazife Sule Yasar Bilge (NS)

Department of Internal Medicine, Division of Rheumatology, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey.

Reyhan Bilici Salman (R)

Department of Internal Medicine, Division of Rheumatology, Faculty of Medicine, Gazi University, Ankara.

Gozde Kubra Yardımcı (GK)

Department of Internal Medicine, Division of Rheumatology, Faculty of Medicine, Hacettepe University, Ankara.

Aslihan Avanoglu Guler (A)

Department of Internal Medicine, Division of Rheumatology, Faculty of Medicine, Gazi University, Ankara.

Hazan Karadeniz (H)

Department of Internal Medicine, Division of Rheumatology, Faculty of Medicine, Gazi University, Ankara.

Levent Kilic (L)

Department of Internal Medicine, Division of Rheumatology, Faculty of Medicine, Hacettepe University, Ankara.

Mehmet Akif Ozturk (MA)

Department of Internal Medicine, Division of Rheumatology, Faculty of Medicine, Gazi University, Ankara.

Berna Goker (B)

Department of Internal Medicine, Division of Rheumatology, Faculty of Medicine, Gazi University, Ankara.

Seminur Haznedaroglu (S)

Department of Internal Medicine, Division of Rheumatology, Faculty of Medicine, Gazi University, Ankara.

Umut Kalyoncu (U)

Department of Internal Medicine, Division of Rheumatology, Faculty of Medicine, Hacettepe University, Ankara.

Timucin Kasifoglu (T)

Department of Internal Medicine, Division of Rheumatology, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey.

Abdurrahman Tufan (A)

Department of Internal Medicine, Division of Rheumatology, Faculty of Medicine, Gazi University, Ankara.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH